Literature DB >> 8381782

Isolation and characterization of Bordetella bronchiseptica mutants deficient in siderophore activity.

S K Armstrong1, M O Clements.   

Abstract

Iron acquisition by the gram-negative pathogens Bordetella bronchiseptica and Bordetella pertussis is thought to occur by hydroxamate siderophore-mediated transport as well as an apparently siderophore-independent process by which host transferrins bind to bacterial surface receptors. We constructed B. bronchiseptica mutants deficient in siderophore activity by insertional mutagenesis with miniTn5/lacZ1. The mutants could be placed into four distinct complementation groups, as determined from cross-feeding assays which demonstrated restored siderophore synthesis. Mutants deficient in siderophore activity were BRM1, BRM6, and BRM9, exhibiting approximately 36 to 41% of wild-type siderophore levels, and BRM3 and BRM8, which appeared to produce very little or no detectable siderophore. Mutant BRM4 was found to be a leucine auxotroph, while mutants BRM2 and BRM7 could synthesize siderophore only in low-iron medium which was supplemented with various amino acids. Evaluation of all transcriptional fusions revealed an apparent lack of iron-regulated lacZ expression. Genomic regions flanking the transposable element in the siderophore mutants were homologous with B. pertussis chromosomal DNA, while bioassays suggested siderophore cross-feeding between B. pertussis and B. bronchiseptica. These results indicate probable similarity between the siderophore biosynthetic and transport systems of the two species.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381782      PMCID: PMC193031          DOI: 10.1128/jb.175.4.1144-1152.1993

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  37 in total

1.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

2.  Bordetella bronchiseptica bacteremia.

Authors:  D A Katzenstein; L Ciofalo; M C Jordan
Journal:  West J Med       Date:  1984-01

3.  Regulation of enterobactin iron transport in Escherichia coli: characterization of ent::Mu d(Apr lac) operon fusions.

Authors:  T P Fleming; M S Nahlik; M A McIntosh
Journal:  J Bacteriol       Date:  1983-12       Impact factor: 3.490

4.  Effect of pyridines on phenotypic properties of Bordetella pertussis.

Authors:  D R Schneider; C D Parker
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

Review 5.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 6.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

7.  ColV plasmid-mediated, colicin V-independent iron uptake system of invasive strains of Escherichia coli.

Authors:  P H Williams; P J Warner
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

8.  Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation.

Authors:  J E Bauwens; D H Spach; T W Schacker; M M Mustafa; R A Bowden
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Parenteral vaccination of young swine against Bordetella bronchiseptica.

Authors:  D O Farrington; W P Switzer
Journal:  Am J Vet Res       Date:  1979-10       Impact factor: 1.156

10.  Heptakis(2,6-O-dimethyl)beta-cyclodextrin: a novel growth stimulant for Bordetella pertussis phase I.

Authors:  A Imaizumi; Y Suzuki; S Ono; H Sato; Y Sato
Journal:  J Clin Microbiol       Date:  1983-05       Impact factor: 5.948

View more
  31 in total

1.  Bordetella interspecies allelic variation in AlcR inducer requirements: identification of a critical determinant of AlcR inducer responsiveness and construction of an alcR(Con) mutant allele.

Authors:  Timothy J Brickman; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

2.  Integration of environmental signals controls expression of Bordetella heme utilization genes.

Authors:  Carin K Vanderpool; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

3.  Bordetella AlcS transporter functions in alcaligin siderophore export and is central to inducer sensing in positive regulation of alcaligin system gene expression.

Authors:  Timothy J Brickman; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

4.  Transcriptional analysis of the Bordetella alcaligin siderophore biosynthesis operon.

Authors:  H Y Kang; S K Armstrong
Journal:  J Bacteriol       Date:  1998-02       Impact factor: 3.490

5.  The Bordetella bhu locus is required for heme iron utilization.

Authors:  C K Vanderpool; S K Armstrong
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

6.  The Bordetella bfe system: growth and transcriptional response to siderophores, catechols, and neuroendocrine catecholamines.

Authors:  Mark T Anderson; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

7.  The BfeR regulator mediates enterobactin-inducible expression of Bordetella enterobactin utilization genes.

Authors:  Mark T Anderson; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

8.  bvg Repression of alcaligin synthesis in Bordetella bronchiseptica is associated with phylogenetic lineage.

Authors:  P C Giardina; L A Foster; J M Musser; B J Akerley; J F Miller; D W Dyer
Journal:  J Bacteriol       Date:  1995-11       Impact factor: 3.490

9.  Heme-responsive transcriptional activation of Bordetella bhu genes.

Authors:  Carin K Vanderpool; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

10.  Alcaligin siderophore production by Bordetella bronchiseptica strain RB50 is not repressed by the BvgAS virulence control system.

Authors:  Timothy J Brickman; Sandra K Armstrong
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.